29
Participants
Start Date
June 30, 2016
Primary Completion Date
July 31, 2019
Study Completion Date
December 31, 2019
Saline
Subjects will be studied on 2 occasions, in random order. During the saline study they will be infused with saline.
Exendin-9,39
Subjects will be studied on 2 occasions, in random order. During the Exendin-9,39 study day they will be infused with Exendin-9,39. Exendin-9,39 blocks the actions of specific hormones called incretins, that are produced in the gut in health and in larger quantities after gastric bypass surgery.
Mayo Clinic in Rochester, Rochester
Lead Sponsor
The Obesity Society
OTHER
Mayo Clinic
OTHER